# A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies

> **NCT05379634** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Janssen Research & Development, LLC** · enrollment: 36 (actual)

## Conditions studied

- Myositis

## Interventions

- **DRUG:** Nipocalimab
- **OTHER:** Placebo
- **DRUG:** Glucocorticoids

## Key facts

- **NCT ID:** NCT05379634
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-05
- **Primary completion:** 2025-09-04
- **Final completion:** 2026-09-16
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05379634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05379634, "A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05379634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*